Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events mdic patient centered benefit risk assessment public event introducing framework
Market Research We can collaborate with you to develop and support marketing strategies for your pharmaceutical products and/or devices. Our market research services include: Qualitative research (interviews and focus groups) with patients, physicians, …
… product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated … valuation. WTP studies provide a monetary measure of benefit and can answer questions like what’s it worth to a patient if: The dosing regimen changes from 3 times a day to …
… Equity, Diversity, Inclusion, and Belonging in Patient Centered Drug Development Chad Downey, BS Associate Director, … Advancing equity, diversity, inclusion, and belonging in patient centered drug development with patient preference …
… offers vast potential, it comes with challenges. From the risk of errors like "hallucinations" to overlooking ethical … Real-World Evidence HTA and Reimbursement Submissions Patient-Centered Outcomes Assessment Health Preference Assessment …
… 15th European Public Health Conference 2022 (EPH) Share on: Wednesday, … researchers will be presented at the 15th European Public Health Conference 2022 (EPH). Knowledge and attitudes … HCPs towards hepatitis A and B vaccination of adults at risk. Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, …
… treatment effects is an important part of evaluating the benefit-risk balance of their products. However, primary efficacy … effects on efficacy, safety, and quality of life in the patient population and in subgroups of interest. In the …
… are several key inflection points in the joint clinical assessment (JCA) process. The first is when they receive a dossier submission request from the Health Technology Assessment (HTA) Coordination Group. This request will … the final report. The pressing question is this: Will this framework and timeline be effectively workable in practice, …
… and Caregivers Dana DiBenedetti, PhD Executive Director, Patient-Centered Outcomes Assessment The devastating effects that … of therapies that have the potential to provide meaningful benefit to these patients, it also provides a base for …
… Emergence of the Joint Clinical Assessment in the European Union Anne Heyes, MBA Vice … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by … viewpoints, with a particular focus on payer- and patient-relevant endpoints, such as clinical outcomes …
… institute, RTI International, which administers our benefit offerings. Visit the institute's benefits page to …